StonvexLoading…
StonvexStonvexStonvexCore line items from CNH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.47B | $3.17B | $15.35B | $10.89B | $7.19B |
Operating Income | Not available | $13.00M | $620.00M | $488.00M | $437.00M |
Net Income | Not available | $7.00M | $510.00M | $424.00M | $344.00M |
EPS (Diluted) | $0.10 | $0.01 | $0.41 | $0.34 | $0.27 |
Total Assets | Not available | $42.04B | $42.75B | $43.26B | $43.69B |
Total Liabilities | Not available | $34.17B | $34.92B | $35.42B | $35.85B |
Cash & Equivalents | Not available | $1.60B | $2.58B | $2.30B | $2.51B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 1.24B | 1.24B | 1.25B | 1.25B |